Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiopharmaceuticals in PET, progress and promise

Conference ·
OSTI ID:6651175
It is the intention of this presentation to focus on the current state of radiopharmaceuticals for PET and where this is leading us. PET radiopharmaceuticals can be broken down into perhaps seven categories at present with each being applicable to a different aspect of human biochemistry. These are: metabolic probes, neurochemical probes, enzyme probes, ion channel blockers, blood flow agents, ethical drugs and other positron emitters. 7 refs.
Research Organization:
Brookhaven National Lab., (BNL) Upton, NY (USA)
Sponsoring Organization:
U.S. Department of Energy (USDOE)
DOE Contract Number:
AC02-76CH00016
OSTI ID:
6651175
Report Number(s):
BNL-41981; CONF-8811103-1; ON: DE89002941
Country of Publication:
United States
Language:
English